Literature DB >> 17084810

New parenthood as a risk factor for the development of obsessional problems.

Nichole Fairbrother1, Jonathan S Abramowitz.   

Abstract

Research on emotional disturbance during pregnancy and the postpartum period has focused primarily on mood disorders and psychosis, yet preliminary evidence suggests that early parenthood is also associated with an increased risk for the development and exacerbation of obsessional problems. In this article we describe the nature of "postpartum obsessive-compulsive disorder" (ppOCD) and present a cognitive-behavioural model to account for these signs and symptoms. The model outlines features of early parenthood that might increase vulnerability to ppOCD and proposes a conceptual framework similar to that described in cognitive-behavioural models of OCD in general. The empirical status of the model described herein is discussed, along with suggestions for future research and implications for treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17084810     DOI: 10.1016/j.brat.2006.09.019

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  10 in total

1.  Obsessive-compulsive disorder in pregnancy and the postpartum period: course of illness and obstetrical outcome.

Authors:  Samuel J House; Shanti P Tripathi; Bettina T Knight; Natalie Morris; D Jeffrey Newport; Zachary N Stowe
Journal:  Arch Womens Ment Health       Date:  2015-07-16       Impact factor: 3.633

2.  Are we overlooking obsessive-compulsive disorder during and after pregnancy? Some arguments for a peripartum onset specifier.

Authors:  Verinder Sharma; Dwight Mazmanian
Journal:  Arch Womens Ment Health       Date:  2020-05-26       Impact factor: 3.633

3.  Stress response in postpartum women with and without obsessive-compulsive symptoms: an fMRI study.

Authors:  Catherine Lord; Meir Steiner; Claudio N Soares; Caitlin L Carew; Geoffrey B Hall
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

4.  Modeling of Compulsive Behavior Types of Obsessive-Compulsive Disorder Patients by Using the Data Mining Method.

Authors:  Şaban Karayağız; Burcu Oralhan; Zeki Oralhan; Hamza Turabieh; Monirujjaman Khan
Journal:  Comput Math Methods Med       Date:  2022-04-23       Impact factor: 2.809

5.  Obsessive-compulsive symptoms during the postpartum period. A prospective cohort.

Authors:  Emily S Miller; Christine Chu; Jacqueline Gollan; Dana R Gossett
Journal:  J Reprod Med       Date:  2013 Mar-Apr       Impact factor: 0.142

6.  Developmental estrogen exposures and disruptions to maternal behavior and brain: Effects of ethinyl estradiol, a common positive control.

Authors:  Mary C Catanese; Laura N Vandenberg
Journal:  Horm Behav       Date:  2017-11-08       Impact factor: 3.587

7.  Peripartum complications associated with obsessive compulsive disorder exacerbation during pregnancy.

Authors:  Calliope Holingue; Jack Samuels; Valeria Guglielmi; Wendy Ingram; Gerald Nestadt; Paul S Nestadt
Journal:  J Obsessive Compuls Relat Disord       Date:  2021-03-22       Impact factor: 1.677

8.  Delayed sleep timing and circadian rhythms in pregnancy and transdiagnostic symptoms associated with postpartum depression.

Authors:  Jessica L Obeysekare; Zachary L Cohen; Meredith E Coles; Teri B Pearlstein; Carmen Monzon; E Ellen Flynn; Katherine M Sharkey
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

9.  The Postpartum Obsessive-Compulsive Scale: Psychometric, Operative and Epidemiologic Study in a Portuguese Sample.

Authors:  Ana Telma Pereira; Ana Araújo; Julieta Azevedo; Cristiana C Marques; Maria João Soares; Carolina Cabaços; Mariana Marques; Daniela Pereira; Michele Pato; António Macedo
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

10.  Intimate partner abuse before and during pregnancy as risk factors for postpartum mental health problems.

Authors:  Sarah L Desmarais; Ashley Pritchard; Evan M Lowder; Patricia A Janssen
Journal:  BMC Pregnancy Childbirth       Date:  2014-04-07       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.